Stingray expands in Europe with Paris acquisition
Pan-European radiotherapy leader Stingray Healthcare Group has acquired the Porte de Saint-Cloud Oncology Centre from the American Hospital of Paris. The transaction was executed through Stingray’s French subsidiary, Amethyst, and marks a significant consolidation in the competitive French healthcare market. Located in Boulogne-Billancourt, the acquired facility is a major regional radiotherapy and oncology provider, delivering approximately 42,000 radiotherapy sessions and…